Cargando…

Effects of different doses of erythropoietin in patients with myelodysplastic syndromes: A propensity score‐matched analysis

BACKGROUND: Erythropoiesis‐stimulating agents effectively improve the hemoglobin levels in a fraction of anemic patients with myelodysplastic syndromes (MDS). Higher doses (HD) of recombinant human erythropoietin (rhEPO) have been proposed to overcome suboptimal response rates observed in MDS patien...

Descripción completa

Detalles Bibliográficos
Autores principales:	Balleari, Enrico, Filiberti, Rosa Angela, Salvetti, Chiara, Allione, Bernardino, Angelucci, Emanuele, Bruzzone, Marco, Calzamiglia, Tullio, Cavaliere, Marina, Cavalleri, Maurizio, Cilloni, Daniela, Clavio, Marino, Crisà, Elena, Da Col, Anna, Danise, Paolo, Pilo, Federica, Ferrero, Dario, Finelli, Carlo, Gioia, Daniela, Lemoli, Roberto Massimo, Masiera, Elisa, Messa, Emanuela, Miglino, Maurizio, Musto, Pellegrino, Natalie Oliva, Esther, Poloni, Antonella, Salvi, Flavia, Sanna, Alessandro, Scudeletti, Marco, Tassara, Rodolfo, Santini, Valeria
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2019
Materias:	Clinical Cancer Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6912022/ https://www.ncbi.nlm.nih.gov/pubmed/31657156 http://dx.doi.org/10.1002/cam4.2638

Ejemplares similares

A phase II, multicentre trial of decitabine in higher-risk chronic myelomonocytic leukemia
por: Santini, V, et al.
Publicado: (2018)

PB2672: EXPLORING UNMET NEEDS OF PATIENTS WITH MYELODYSPLASTIC NEOPLASMS AND CAREGIVERS IN A NATIONAL ITALIAN SURVEY
por: Crisà, Elena, et al.
Publicado: (2023)

Iron Chelation Therapy in Myelodysplastic Syndromes
por: Messa, Emanuela, et al.
Publicado: (2010)

Depletion of SIRT6 enzymatic activity increases acute myeloid leukemia cells’ vulnerability to DNA-damaging agents
por: Cagnetta, Antonia, et al.
Publicado: (2018)

SARS-CoV-2 in Myelodysplastic Syndromes: A Snapshot From Early Italian Experience
por: Mossuto, Sandra, et al.
Publicado: (2020)

Mechanisms and Clinical Applications of Genome Instability in Multiple Myeloma
por: Cagnetta, Antonia, et al.
Publicado: (2015)

Targeting the deacetylase SIRT6 unveils spliceosome deregulation as exploitable vulnerability for aggressive myeloma
por: Gelli, Elisa, et al.
Publicado: (2023)

Fludarabine, High-Dose Cytarabine and Idarubicin-Based Induction May Overcome the Negative Prognostic Impact of FLT3-ITD in NPM1 Mutated AML, Irrespectively of FLT3-ITD Allelic Burden
por: Minetto, Paola, et al.
Publicado: (2020)

The new small tyrosine kinase inhibitor ARQ531 targets acute myeloid leukemia cells by disrupting multiple tumor-addicted programs
por: Soncini, Debora, et al.
Publicado: (2019)

Iron Toxicity and Hemopoietic Cell Transplantation: Time to Change the Paradigm
por: Pilo, Federica, et al.
Publicado: (2019)

Iron overload alters the energy metabolism in patients with myelodysplastic syndromes: results from the multicenter FISM BIOFER study
por: Cilloni, Daniela, et al.
Publicado: (2020)

Effectiveness and Safety of Immune Checkpoint Inhibitors for Patients with Advanced Non Small-Cell Lung Cancer in Real-World: Review and Meta-Analysis
por: Mencoboni, Manlio, et al.
Publicado: (2021)

Arsenic trioxide and ascorbic acid interfere with the BCL2 family genes in patients with myelodysplastic syndromes: an ex-vivo study
por: Galimberti, Sara, et al.
Publicado: (2012)

Autologous Hematopoietic Stem Cell Transplantation (AHSCT): Standard of Care for Relapsing–Remitting Multiple Sclerosis Patients
por: Bertolotto, Antonio, et al.
Publicado: (2020)

Analysis of Erythrocyte Glycophorin-A Variants by Flow Cytometry in Lung Disease Patients Detects the Effect of Tobacco Smoke
por: Neri, Monica, et al.
Publicado: (2000)

Post-Transplant Nivolumab Plus Unselected Autologous Lymphocytes in Refractory Hodgkin Lymphoma: A Feasible and Promising Salvage Therapy Associated With Expansion and Maturation of NK Cells
por: Guolo, Fabio, et al.
Publicado: (2021)

Strategies for minimal residual disease detection: current perspectives
por: Andreani, Giacomo, et al.
Publicado: (2019)

S217: POST-TRANSPLANT NIVOLUMAB PLUS UNSELECTED AUTOLOGOUS LYMPHOCYTES IN REFRACTORY HODGKIN LYMPHOMA RESULTS IN VERY HIGH REMISSION RATE AND EXCELLENT SURVIVAL AND IT IS ASSOCIATED WITH NK CELL EXPANSION
por: Guolo, Fabio, et al.
Publicado: (2023)

PB2177: MULTICENTRE RETROSPECTIVE OBSERVATIONAL STUDY ON PATIENTS WITH MYELOFIBROSIS IN PIEDMONT. ROLE OF INFLAMMATION AND DYSIMMUNITY. MFACTORS STUDY.
por: Bonuomo, Valentina, et al.
Publicado: (2023)

Myelodysplastic Syndromes and Iron Chelation Therapy
por: Angelucci, Emanuele, et al.
Publicado: (2017)

A new BCR-ABL1 Drosophila model as a powerful tool to elucidate the pathogenesis and progression of chronic myeloid leukemia
por: Bernardoni, Roberto, et al.
Publicado: (2019)

Standardization of BCR-ABL1 p210 Monitoring: From Nested to Digital PCR
por: Jovanovski, Aleksandar, et al.
Publicado: (2020)

Peripheral blasts are associated with responses to ruxolitinib and outcomes in patients with chronic‐phase myelofibrosis
por: Palandri, Francesca, et al.
Publicado: (2022)

CD38-Induced Metabolic Dysfunction Primes Multiple Myeloma Cells for NAD(+)-Lowering Agents
por: Becherini, Pamela, et al.
Publicado: (2023)

Characterization of Tunable Micro-Lenses with a Versatile Optical Measuring System
por: Merlo, Sabina, et al.
Publicado: (2018)

Drug Delivery Applications of Three-Dimensional Printed (3DP) Mesoporous Scaffolds
por: Limongi, Tania, et al.
Publicado: (2020)

SF3B1 Mutations in Hematological Malignancies
por: Cilloni, Daniela, et al.
Publicado: (2022)

A Leukemic Target with a Thousand Faces: The Mitochondria
por: Maffeo, Beatrice, et al.
Publicado: (2023)

P530: CPX-351 INDUCTION IS ABLE TO INDUCE MRD NEGATIVE CR IN A SIGNIFICATIVE PROPORTION OF VERY HIGH RISK AML PATIENTS, REGARDLESS OF MUTATIONAL BURDEN, ALLOWING FOR BRIDGING TO TRANSPLANTATION
por: Riva, Carola, et al.
Publicado: (2023)

Outbreak of SARS-CoV-2 Lineage 20I/501Y.V1 in a Nursing Home Underlines the Crucial Role of Vaccination in Both Residents and Staff
por: Orsi, Andrea, et al.
Publicado: (2021)

Basic emotions and adaptation. A computational and evolutionary model
por: Pacella, Daniela, et al.
Publicado: (2017)

P381: FULL PEDIATRIC INDUCTION IN ADULTS AGED UP TO 55 YEARS WITH PHILADELPHIA-NEGATIVE ACUTE LYMPHOBLASTIC LEUKEMIA IS WELL TOLERATED AND RESULTS IN VERY HIGH CURE RATE
por: Maio, Elena, et al.
Publicado: (2023)

PB1742: FEASIBILITY AND EFFICACY OF A PEG-ASPARAGINASE-BASED TREATMENT PROTOCOL IN ELDERLY PHILADELPHIA-NEGATIVE ACUTE LYMPHOBLASTIC LEUKEMIA PATIENTS
por: Vernarecci, Chiara, et al.
Publicado: (2023)

Soluble HLA Class I and Class II Molecule Levels in Serum and Cerebrospinal Fluid of Multiple Sclerosis Patients
por: Filaci, Gilberto, et al.
Publicado: (1997)

Anemia in the Elderly: not Always what it Seems
por: Cerrano, Marco, et al.
Publicado: (2016)

Testing of Piezo-Actuated Glass Micro-Membranes by Optical Low-Coherence Reflectometry
por: Merlo, Sabina, et al.
Publicado: (2017)

Detection of SF3B1 p.Lys700Glu Mutation by PNA-PCR Clamping in Myelodysplastic Syndromes and Myeloproliferative Neoplasms
por: Petiti, Jessica, et al.
Publicado: (2022)

Chemically stable inhibitors of 14-3-3 protein–protein interactions derived from BV02
por: Iralde-Lorente, Leire, et al.
Publicado: (2019)

A Prognostic Model to Predict Ruxolitinib Discontinuation and Death in Patients with Myelofibrosis
por: Palandri, Francesca, et al.
Publicado: (2023)

Revealing the Mysteries of Acute Myeloid Leukemia: From Quantitative PCR through Next-Generation Sequencing and Systemic Metabolomic Profiling
por: Panuzzo, Cristina, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_lb4sktoh3rsn1ttp5drms482r5